Using Radiation-free Ultrasound for Screening Scoliosis Among Female School Children in Hong Kong to Reduce Unnecessary X-ray Exposure
Launched by CHINESE UNIVERSITY OF HONG KONG · Feb 11, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to screen for scoliosis, which is a condition where the spine curves abnormally. Instead of using X-rays, which can expose children to radiation, the researchers want to see if a special ultrasound system can safely identify girls who need further evaluation for scoliosis. The focus is on young female students around the age of ten who are at risk for scoliosis progression and may need more regular monitoring or treatment.
To be eligible for the trial, participants must be school-aged girls in Hong Kong who are part of a scoliosis screening program and have had their first menstrual period for no more than nine months. Girls who have certain health issues or conditions that could interfere with the ultrasound exam, like skin diseases or recent surgeries, will not be included. Those who participate can expect a safe and non-invasive ultrasound procedure, which is a quick and painless way to assess their spine without the risks associated with X-rays. This study aims to make scoliosis screening safer and more effective for young girls.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • i. School children in Hong Kong attending School Screening Program provided by Student Health Service ii. Recommended for radiographic assessment in the scoliosis screening program iii. Female with year since menarche of equal to or less than 9 months
- Exclusion Criteria:
- • i. Patients with standing height \<1 m, or \>2 m ii. Patients with body mass index (BMI) ≥25 kg/m2 iii. Subjects with skin diseases iv. Subjects with fracture or wound that affect ultrasound scanning v. Subjects with ferromagnetic implants vi. Subjects with surgery done for the spine vii. Subjects with winged scapula or other irregularity of back contour that affect ultrasound scanning viii. Subjects who cannot stand steadily during scanning ix. Subjects with allergy to ultrasound gel
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Tsz-ping Lam, FHKAM(Ortho Surg)
Principal Investigator
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported